Rinsho Shinkeigaku. 2009 Nov; 49(11) : 834-6. Future of stem cell therapy for neuronal regeneration – [Article in Japanese] Takaha shi J . Department of Biological Repair, Institute for Frontier Medical Sciences, Kyoto University. Abstract Embryonic stem (ES) cells are expected as promising donor cells for cell transplantation therapy. For example, mouse or monkey ES…

Adv Exp Med Biol. 2010; 671 : 41-57. Stem cell transplantation methods. Tran KD, Ho A, Jandial R. UCSD School of Medicine, San Diego, California, USA. Abstract Just a few short years ago, we still used to think that we were born with a finite number of irreplaceable neurons. However, in recent years, there has…

J Neuroimmunol. 2009 Nov 30; 216(1-2) : 39-50. Epub 2009 Oct 9. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease. Chao YX, He BP, Tay SS. Department of Anatomy, Yong Loo Lin School of Medicine,…

Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3 : S171-5. How useful are stem cells in PD therapy? Luo Y, Kuang SY, Hoffer B. National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. Abstract Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The onset of PD is usually…

ILAR J. 2009; 51(1) : 24-41. Preclinical assessment of stem cell therapies for neurological diseases. Joers VL, Emborg ME. Neuroscience Training Program, University of Wisconsin, Madison, WI, USA. Abstract Stem cells, as subjects of study for use in treating neurological diseases, are envisioned as a replacement for lost neurons and glia, a means of trophic…

Stem Cells. 2009 Nov; 27(11) : 2846-56. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule. Ourednik V, Ourednik J, Xu Y, Zhang Y, Lynch WP, Snyder EY, Schachner M. Department of Biomedical Sciences, VetMed, Iowa State University, Ames, Iowa, USA. Abstract In the injured…

Int J Pharm. 2009 Nov 3; 381(2) : 113-21. Epub 2009 Mar 19. Pluripotent stem cells as new drugs? The example of Parkinson’s disease. Preynat-Seauve O, Burkhard PR, Villard J, Zingg W, Ginovart N, Feki A, Dubois-Dauphin M, Hurst SA, Mauron A, Jaconi M, Krause KH. Department of Genetic and Laboratory Medicine, Geneva University Hospitals,…

Neurosurgery. 2009 Oct; 65(4) : 741-53; discussion 753. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain. Mine Y, Hayashi T, Yamada M, Okano H, Kawase T. Department of Neurosurgery, School of Medicine, Keio University, Tokyo, Japan. Erratum in: Neurosurgery. 2009 Dec;65(6):1062. Abstract OBJECTIVE: To physiologically repair damaged…

Sci China C Life Sci. 2009 Jul; 52(7) : 610-4. Epub 2009 Jul 30. Cells therapy for Parkinson’s disease–so close and so far away. Ren Z, Zhang Y. Cell Therapy Center, Xuanwu Hospital, Capital Medical University and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing, 100053, China. Abstract One of the strategies of treating Parkinson’s…

Biochim Biophys Acta. 2009 Jul; 1792(7) : 688-702. Epub 2008 Oct 25. Cell replacement therapy for Parkinson’s disease. Wijeyekoon R, Barker RA. Cambridge Centre for Brain Repair, Forvie Site, Cambridge, UK. Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disorder in which the degeneration of dopaminergic neurons projecting from the substantia nigra to the striatum…